{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T02:59:56Z","timestamp":1789181996941,"version":"build-2803163510"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T00:00:00Z","timestamp":1696809600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Fluoroquinolones (FQs) are not commonly prescribed in children, yet the increasing incidence of multidrug-resistant (MDR) Enterobacterales (Ent) infections in this population often reveals FQ resistance. We sought to define the role of FQ resistance in the epidemiology of MDR Ent in children, with an overall goal to devise treatment and prevention strategies.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A case\u2013control study of children (0\u201318 years) at three Chicago hospitals was performed. Cases had infections by FQ-susceptible, \u03b2-lactamase-producing (<jats:italic>bla<\/jats:italic>) Ent harboring a non- or low-level expression of PMFQR genes (PMFQS Ent). Controls had FQR infections due to <jats:italic>bla<\/jats:italic> Ent with expressed PMFQR genes (PMFQR Ent). We sought <jats:italic>bla<\/jats:italic> genes by PCR or DNA (BD Max Check-Points assay<jats:sup>\u00ae<\/jats:sup>) and PMFQR genes by PCR. We performed rep-PCR, MLST, and <jats:italic>E. coli<\/jats:italic> phylogenetic grouping. Whole genome sequencing was additionally performed on PMFQS Ent positive isolates. Demographics, comorbidities, and device, antibiotic, and healthcare exposures were evaluated. Predictors of infection were assessed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of 170 \u03b2-lactamase-producing Ent isolates, 85 (50%) were FQS; 23 (27%) had PMFQR genes (PMFQS cases). Eighty-five (50%) were FQR; 53 (62%) had PMFQR genes (PMFQR controls). The median age for children with PMFQS Ent and PMFQR Ent was 4.3 and 6.2 years, respectively (<jats:italic>p<\/jats:italic> = NS). Of 23 PMFQS Ent, 56% were <jats:italic>Klebsiella<\/jats:italic> spp., and of 53 PMFQR Ent, 76% were <jats:italic>E. coli<\/jats:italic>. The most common <jats:italic>bla<\/jats:italic> and PMFQR genes detected in PMFQS Ent were <jats:italic>bla<\/jats:italic><jats:sub>SHV ESBL<\/jats:sub> (44%) and <jats:italic>oqxAB<\/jats:italic> (57%), and the corresponding genes detected in PMFQR Ent were <jats:italic>bla<\/jats:italic><jats:sub>CTX-M-1-group ESBL<\/jats:sub> (79%) and <jats:italic>aac(6\u2019)-Ib-cr<\/jats:italic> (83%). Whole genome sequencing of PMFQS Ent revealed the additional presence of <jats:italic>mcr-9<\/jats:italic>, a transferable polymyxin resistance gene, in 47% of isolates, along with multiple plasmids and mobile genetic elements propagating drug resistance. Multivariable regression analysis showed that children with PMFQS Ent infections were more likely to have hospital onset infection (OR 5.7, 95% CI 1.6\u201322) and isolates containing multiple <jats:italic>bla<\/jats:italic> genes (OR 3.8, 95% CI 1.1\u201314.5). The presence of invasive devices mediated the effects of healthcare setting in the final model. Differences in demographics, comorbidities, or antibiotic use were not found.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Paradoxically, PMFQS Ent infections were often hospital onset and PMFQR Ent infections were community onset. PMFQS Ent commonly co-harbored multiple <jats:italic>bla<\/jats:italic> and PMFQR genes, and additional silent, yet transferrable antibiotic resistance genes such as <jats:italic>mcr-9<\/jats:italic>, affecting therapeutic options and suggesting the need to address infection prevention strategies to control spread. Control of PMFQS Ent infections will require validating community and healthcare-based sources and risk factors associated with acquisition.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcimb.2023.1249505","type":"journal-article","created":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T11:36:33Z","timestamp":1696851393000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["The role of the plasmid-mediated fluoroquinolone resistance genes as resistance mechanisms in pediatric infections due to Enterobacterales"],"prefix":"10.3389","volume":"13","author":[{"given":"Latania K.","family":"Logan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura Rojas","family":"Coy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire E.","family":"Pitstick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven H.","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel L.","family":"Medernach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. Nicholas","family":"Domitrovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sreenivas","family":"Konda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia K.","family":"Qureshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea M.","family":"Hujer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaotian","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan D.","family":"Rudin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Weinstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Bonomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,10,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"3216","DOI":"10.1128\/IAI.70.6.3216-3226.2002","article-title":"Phylogenetic analysis and prevalence of urosepsis strains of Escherichia coli bearing pathogenicity island-like domains","volume":"70","author":"Bingen-Bidois","year":"2002","journal-title":"Infect. Immun."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1128\/JCM.06131-11","article-title":"Phenotypic screening of carbapenemases and associated beta-lactamases in carbapenem-resistant Enterobacteriaceae","volume":"50","author":"Birgy","year":"2012","journal-title":"J. Clin. Microbiol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1128\/JCM.02229-08","article-title":"Detection of plasmid-mediated quinolone resistance genes in clinical isolates of Enterobacter spp","volume":"47","author":"Cano","year":"2009","journal-title":"Spain J. Clin. Microbiol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.mib.2006.08.011","article-title":"The CTX-M \u03b2-lactamase pandemic","volume":"9","author":"Cant\u00f3n","year":"2006","journal-title":"Curr. Opin. Microbiol."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2012.00110","article-title":"CTX-M enzymes: Origin and diffusion","volume":"3","author":"Canton","year":"2012","journal-title":"Front. Microbiol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"5623","DOI":"10.1128\/AAC.01267-16","article-title":"Detection of mcr-1 among Escherichia coli Clinical isolates collected worldwide as part of the SENTRY antimicrobial surveillance program in 2014 and 2015","volume":"60","author":"Castanheira","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"B7","volume-title":"CRE toolkit\u2013guidance for control of carbapenem-resistant Enterobacteriaceae (CRE)","year":"2015"},{"key":"B8","unstructured":"Healthcare-Associated Infections: CRE Technical Information2019"},{"key":"B9","doi-asserted-by":"publisher","first-page":"3423","DOI":"10.1128\/AAC.06191-11","article-title":"Prevalence of qnr, aac(6\u2019)-Ib-cr, qepA, and oqxAB in Escherichia coli isolates from humans, animals, and environment","volume":"56","author":"Chen","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"B10","unstructured":"Performance standards for antimicrobial susceptibility testing: M100-ED33. Thirty-third informational supplement (March 2023 update)2023"},{"key":"B11","doi-asserted-by":"publisher","first-page":"4178","DOI":"10.1128\/JCM.43.8.4178-4182.2005","article-title":"Multilocus sequence typing of klebsiella pneumoniae nosocomial isolates","volume":"43","author":"Diancourt","year":"2005","journal-title":"J. Clin. Microbiol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1093\/jac\/dkn547","article-title":"Characterization of blaKPC-containing klebsiella pneumoniae isolates detected in different institutions in the eastern USA","volume":"63","author":"Endimiani","year":"2009","journal-title":"J. Antimicrob. Chemother."},{"key":"B13","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1089\/mdr.2005.11.378","article-title":"The prevalence of the OqxAB multidrug efflux pump amongst olaquindox-resistant Escherichia coli in pigs","volume":"11","author":"Hansen","year":"2005","journal-title":"Microb. Drug Resist."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1128\/JCM.02380-08","article-title":"Rapid determination of quinolone resistance in Acinetobacter spp","volume":"47","author":"Hujer","year":"2009","journal-title":"J. Clin. Microbiol."},{"key":"B15","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/978-3-319-46718-4_17","article-title":"Plasmid-mediated quinolone resistance","volume-title":"Antimicrobial drug resistance","author":"Jacoby","year":"2017"},{"key":"B16","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1186\/1471-2164-9-560","article-title":"Phylogenetic and genomic diversity of human bacteremic Escherichia coli strains","volume":"9","author":"Jaureguy","year":"2008","journal-title":"BMC Genomics"},{"key":"B17","doi-asserted-by":"publisher","first-page":"124","DOI":"10.12688\/wellcomeopenres.14826.1","article-title":"Open-access bacterial population genomics: BIGSdb software, the PubMLST.org website and their applications","volume":"3","author":"Jolley","year":"2018","journal-title":"Wellcome Open Res."},{"key":"B18","doi-asserted-by":"publisher","first-page":"977","DOI":"10.15585\/mmwr.mm6536e2","article-title":"Investigation of first identified mcr-1 gene in an isolate from a US patient\u2014Pennsylvania, 2016","volume":"65","author":"Kline","year":"2016","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"B19","doi-asserted-by":"publisher","first-page":"3087","DOI":"10.1093\/jac\/dkaa205","article-title":"Epidemiology of mobile colistin resistance genes mcr-1 to mcr-9","volume":"75","author":"Ling","year":"2020","journal-title":"J. Antimicrob. Chem."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(15)00424-7","article-title":"Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: A microbiological and molecular biological study","volume":"16","author":"Liu","year":"2015","journal-title":"Lancet Infect. Dis."},{"key":"B21","article-title":"Antibiotic resistance","volume-title":"Feigin and cherry\u2019s textbook of pediatric infectious diseases","author":"Logan","year":"2018"},{"key":"B22","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1093\/jpids\/piu010","article-title":"Extended-spectrum \u03b2-lactamase\u2013producing and third-generation cephalosporin-resistant Enterobacteriaceae in children: Trends in the United States, 1999\u20132011","volume":"3","author":"Logan","year":"2014","journal-title":"J. Pediatr. Infect. Dis. Society."},{"key":"B23","doi-asserted-by":"publisher","first-page":"3462","DOI":"10.1128\/AAC.00098-16","article-title":"Analysis of beta-lactamase resistance determinants in Enterobacteriaceae from Chicago children: A multicenter survey","volume":"60","author":"Logan","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"B24","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s40121-019-0237-2","article-title":"The clinical and molecular epidemiology of CTX-M-9 group producing Enterobacteriaceae infections in children","volume":"8","author":"Logan","year":"2019","journal-title":"Infect. Dis. Ther."},{"key":"B25","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1097\/INF.0000000000002205","article-title":"Community origins and regional differences highlight risk of plasmid-mediated fluoroquinolone resistant Enterobacteriaceae infections in children","volume":"38","author":"Logan","year":"2019","journal-title":"Pediatr. Infect. Dis. J."},{"key":"B26","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1097\/INF.0000000000002176","article-title":"A multi-centered case-case-control study of factors associated with klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae (KPC-CRE) infections in children and young adults","volume":"38","author":"Logan","year":"2019","journal-title":"Pediatr. Infect. Dis. J."},{"key":"B27","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.3201\/eid2111.150548","article-title":"Carbapenem-resistant enterobacteriaceae in children, United States, 1999\u20132012","volume":"21","author":"Logan","year":"2015","journal-title":"Emerg. Infect. Dis."},{"key":"B28","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1097\/INF.0000000000002916","article-title":"A multicentered study of the clinical and molecular epidemiology of TEM-and SHV-type extended-spectrum beta-lactamase producing Enterobacterales infections in children","volume":"40","author":"Logan","year":"2020","journal-title":"Pediatr. Infect. Dis. J."},{"key":"B29","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.1093\/infdis\/jiw282","article-title":"The epidemiology of carbapenem-resistant Enterobacteriaceae: The impact and evolution of a global menace","volume":"215","author":"Logan","year":"2017","journal-title":"J. Infect. Dis."},{"key":"B30","doi-asserted-by":"publisher","first-page":"e02310","DOI":"10.1128\/AAC.02310-19","article-title":"A pilot study of waterways as reservoirs of multi-drug resistant Enterobacteriaceae (MDR Ent) in a high-risk region for community-acquired MDR-Ent infection in children","volume":"64","author":"Logan","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1093\/cid\/civ020","article-title":"Extended-spectrum beta-lactamase-producing Enterobacteriaceae in children: Old foe, emerging threat","volume":"60","author":"Lukac","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"B32","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1128\/CMR.00116-14","article-title":"The role of epidemic resistance plasmids and international high-risk clones in the spread of multidrug-resistant Enterobacteriaceae","volume":"28","author":"Mathers","year":"2015","journal-title":"Clin. Microbiol. Rev."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.idc.2017.11.001","article-title":"The growing threat of antibiotic resistance in children","volume":"32","author":"Medernach","year":"2018","journal-title":"Infect. Dis. Clin. North Am."},{"key":"B34","doi-asserted-by":"publisher","first-page":"e00511","DOI":"10.1128\/aac.00511-22","article-title":"Escherichia coli ST1193: Following in the footsteps of E. coli ST131","volume":"66","author":"Pitout","year":"2022","journal-title":"J. Antimicrob. Chem."},{"key":"B35","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.diagmicrobio.2017.04.011","article-title":"Performance of the checkpoints check-MDR CT103XL assay utilizing the CDC\/FDA antimicrobial resistance isolate bank","volume":"88","author":"Powell","year":"2017","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"B36","doi-asserted-by":"publisher","first-page":"e00377","DOI":"10.1128\/mBio.00377-13","article-title":"The epidemic of extended-spectrum-beta-lactamase-producing Escherichia coli ST131 is driven by a single highly pathogenic subclone, H30-rx","volume":"4","author":"Price","year":"2013","journal-title":"MBio"},{"key":"B37","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S1473-3099(06)70599-0","article-title":"The worldwide emergence of plasmid-mediated quinolone resistance","volume":"6","author":"Robicsek","year":"2006","journal-title":"Lancet Infect. Dis."},{"key":"B38","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1146\/annurev.publhealth.29.020907.090904","article-title":"Industrial food animal production, antimicrobial resistance, and human health","volume":"29","author":"Silbergeld","year":"2008","journal-title":"Annu. Rev. Public Health"},{"key":"B39","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1093\/cid\/ciy525","article-title":"Rapid and extensive expansion in the United States of a new multidrug-resistant Escherichia coli clonal group, sequence type 1193","volume":"68","author":"Tchesnokova","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"B40","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.1128\/AAC.02558-14","article-title":"Pediatric infection and intestinal carriage due to extended-spectrum-cephalosporin-resistant Enterobacteriaceae","volume":"58","author":"Zerr","year":"2014","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2023.1249505\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T09:42:43Z","timestamp":1697190163000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2023.1249505\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,9]]},"references-count":40,"alternative-id":["10.3389\/fcimb.2023.1249505"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2023.1249505","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,9]]},"article-number":"1249505"}}